Questions about a clinical trial?

If you are a patient or a health care provider and would like more information about a clinical trial, please contact our research team.

Reach a BeiGene clinical trial representative

Search Clinical Trials

For a more refined search, use the

  • Age
  • Available Documents
  • Patient Level Data Anonymized patient level data for select studies available to qualified scientific researchers
  • Phases <strong>Phase 1:</strong> A step in clinical research to focus on the safety of a drug and how it works in the body. <strong>Phase 2:</strong> A step in clinical research to gather data on whether a drug works in people who have a certain condition or disease. <strong>Phase 3:</strong> A step in clinical research that gathers more information about a drug’s safety and if it works in people. <strong>Phase 4:</strong> A step in clinical research after regulatory authorities have approved a drug for marketing. <strong>N/A:</strong> For observational studies or interventional studies that do not support drug development.
  • Results
  • Sex In this context, a person’s sex refers to that person’s assigned sex at birth. This has been the case historically; however, there is growing understanding in the healthcare community that this definition excludes certain segments of the population and should be expanded, where possible, to account for gender identity as well. BeiGene recognizes the importance of making clinical trials accessible to all groups of people and is committed to promoting inclusive research.
  • Study Status <strong>Recruiting:</strong> The study is open to enrollment for qualified participants. <strong>Will be Recruiting:</strong> The study has not yet opened enrollment for qualified participants. <strong>Recruitment Complete:</strong> The study is ongoing, and participants are receiving an intervention or being examined, but new potential participants are not currently being recruited or enrolled. <strong>Completed:</strong> The study has ended normally, and participants are no longer receiving an intervention or being examined. <strong>Other:</strong> All other study statuses such as withdrawn, canceled, or terminated.
  • Study Type <strong>Expanded Access:</strong> A way for patients with serious diseases or conditions who cannot participate in a clinical study to gain access to a medical product that has not been approved by regulatory authorities. Also called compassionate use. <strong>Interventional:</strong> A type of clinical trial in which participants are assigned to groups that receive one or more treatment or study drug (intervention). <strong>Observational:</strong> A type of clinical study in which participants may receive diagnostic or study drugs but the study investigator does not assign participants to a a specific intervention or treatment.
  • Vaccine Studies
Clear

Search Results

Study ID
Phase
Condition(s)
Status
Sex
Age Range

BGB-3111-104

1

Healthy Volunteers: Asian, Non-Asian

Completed

All

18 Years to 65 Years   (Adult, Older Adult)

Learn More

BGB-3111-104

Completed

Phase

1

Condition

Healthy Volunteers: Asian, Non-Asian

Sex

All

Age

18 Years to 65 Years   (Adult, Older Adult)

Learn More

BGB-A317-203

2

Classical Hodgkin Lymphoma

Completed

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-203

Completed

Phase

2

Condition

Classical Hodgkin Lymphoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

BGB-3111-206

2

Refractory Mantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma

Completed

All

18 Years to 75 Years   (Adult, Older Adult)

Learn More

BGB-3111-206

Completed

Phase

2

Condition

Refractory Mantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma

Sex

All

Age

18 Years to 75 Years   (Adult, Older Adult)

Learn More

BGB-3111-205

2

Relapsed or Refractory Chronic Lymphocytic Leukemia | Relapsed or Refractory Small Lymphocytic Lymphoma

Completed

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-3111-205

Completed

Phase

2

Condition

Relapsed or Refractory Chronic Lymphocytic Leukemia | Relapsed or Refractory Small Lymphocytic Lymphoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

BGB-3111-1002

1

B-cell Lymphoma

Completed

All

18 Years to 75 Years   (Adult, Older Adult)

Learn More

BGB-3111-1002

Completed

Phase

1

Condition

B-cell Lymphoma

Sex

All

Age

18 Years to 75 Years   (Adult, Older Adult)

Learn More

BGB-3111-207

2

Diffuse Large B-cell Lymphoma

Completed

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-3111-207

Completed

Phase

2

Condition

Diffuse Large B-cell Lymphoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

BGB-3111_BGB-A317_Study_001

1

Lymphoma | Leukemia

Completed

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-3111_BGB-A317_Study_001

Completed

Phase

1

Condition

Lymphoma | Leukemia

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317/BGB-290_Study_001

1

Solid Tumors

Completed

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317/BGB-290_Study_001

Completed

Phase

1

Condition

Solid Tumors

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

BGB-283-AU-001 ACTRN12614001176651

1

Solid Tumors

Completed

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-283-AU-001 ACTRN12614001176651

Completed

Phase

1

Condition

Solid Tumors

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

BGB-3111_GA101_Study_001

1

B-cell Lymphoid Malignancies

Completed

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-3111_GA101_Study_001

Completed

Phase

1

Condition

B-cell Lymphoid Malignancies

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More